Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

611 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The circadian metabolome of atopic dermatitis.
Ratley G, Zeldin J, Chaudhary PP, Yadav M, Paller AS, Zee P, Myles IA, Fishbein A. Ratley G, et al. Among authors: paller as. J Allergy Clin Immunol. 2024 Apr;153(4):1148-1154. doi: 10.1016/j.jaci.2023.11.926. Epub 2024 Jan 21. J Allergy Clin Immunol. 2024. PMID: 38262502
Biologics in the management of childhood atopic dermatitis.
Butala S, Paller AS. Butala S, et al. Among authors: paller as. J Allergy Clin Immunol. 2023 Mar;151(3):681-685. doi: 10.1016/j.jaci.2023.01.010. Epub 2023 Jan 20. J Allergy Clin Immunol. 2023. PMID: 36682587 No abstract available.
Phenotypic and Endotypic Determinants of Atopic Dermatitis Severity From the Atopic Dermatitis Research Network (ADRN) Registry.
Simpson EL, De Benedetto A, Boguniewicz M, Ong PY, Lussier S, Villarreal M, Schneider LC, Paller AS, Guttman-Yassky E, Hanifin JM, Spergel JM, Barnes KC, David G, Austin B, Leung DYM, Beck LA. Simpson EL, et al. Among authors: paller as. J Allergy Clin Immunol Pract. 2023 Aug;11(8):2504-2515. doi: 10.1016/j.jaip.2023.04.052. Epub 2023 May 12. J Allergy Clin Immunol Pract. 2023. PMID: 37182563 Free PMC article.
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 16-Week Trial to Evaluate the Efficacy and Safety of FB-401 in Children, Adolescents, and Adult Subjects (Ages 2 Years and Older) with Mild-to-Moderate Atopic Dermatitis.
Jacobson ME, Myles IA, Paller AS, Eichenfield LF, Simpson EL. Jacobson ME, et al. Among authors: paller as. Dermatology. 2024;240(1):85-94. doi: 10.1159/000532054. Epub 2023 Aug 14. Dermatology. 2024. PMID: 37579728 Clinical Trial.
611 results